sanofi

Press Release: Sanofi to acquire Dren Bios bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipelinePress Release: Sanofi to acquire Dren Bios bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline

Press Release: Sanofi to acquire Dren Bios bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline

Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline Dren Bio deep B-cell…

5 days ago
Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 ReinforcingBest-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohns DiseaseTeva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 ReinforcingBest-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohns Disease

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 ReinforcingBest-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohns Disease

Teva hosting investor call Monday, February 24 at 8:00 a.m. U.S. ET February 22, 2025 02:20 ET  | Source: Teva…

1 month ago
Press Release: Availability of the revised financial statements for Sanofi excluding OpellaPress Release: Availability of the revised financial statements for Sanofi excluding Opella

Press Release: Availability of the revised financial statements for Sanofi excluding Opella

Availability of the revised financial statements for Sanofi excluding Opella Paris, France – December 6, 2024. Following the press release…

4 months ago